These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25831722)

  • 1. [Clinical practice guidelines for the adverse events in medical oncology].
    Isobe T; Hayashi M; Tsubata Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():45-50. PubMed ID: 25831722
    [No Abstract]   [Full Text] [Related]  

  • 2. The American Society of Clinical Oncology guideline program.
    Winn RF; Smith TF
    Pharm Pract Manag Q; 1996 Apr; 16(1):31-8. PubMed ID: 10157738
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of nonrandomized trials in the evaluation of oncology drugs.
    Simon R; Blumenthal GM; Rothenberg ML; Sommer J; Roberts SA; Armstrong DK; LaVange LM; Pazdur R
    Clin Pharmacol Ther; 2015 May; 97(5):502-7. PubMed ID: 25676488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oncology pharmacy specialists in oncology].
    Ikesue H; Oishi R
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):578-82. PubMed ID: 18408426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic therapies administration for adult patients in neuro-oncology: The standards of the Association of the neuro-oncologists of French expression (ANOCEF)].
    Simon N; Vasseur M; Chauffert B; Taillandier L; Le Rhun E
    Bull Cancer; 2016 Apr; 103(4):400-1. PubMed ID: 26874975
    [No Abstract]   [Full Text] [Related]  

  • 6. International medication safety self assessment for oncology practice.
    Johnson PE; Chambers CR; Vaida AJ; Shastay A; Greenall J
    J Oncol Pharm Pract; 2011 Dec; 17(4):303. PubMed ID: 22130772
    [No Abstract]   [Full Text] [Related]  

  • 7. On the evidence. Improving outcomes in colorectal cancer.
    Melville A
    Health Serv J; 1997 Dec; 107(5583):34-5. PubMed ID: 10176081
    [No Abstract]   [Full Text] [Related]  

  • 8. [Not Available].
    Klee H
    Pneumologie; 2016 Dec; 70(12):835. PubMed ID: 27931060
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluating Antiretroviral Therapy Initiation in HIV-Associated Malignancy: Is There Enough Evidence to Inform Clinical Guidelines?
    Oseso LN; Chiao EY; Bender Ignacio RA
    J Natl Compr Canc Netw; 2018 Aug; 16(8):927-932. PubMed ID: 30099368
    [No Abstract]   [Full Text] [Related]  

  • 10. Tackling Cost: A Prescription for Spending Wisely.
    Tempero M
    J Natl Compr Canc Netw; 2019 Jun; 17(6):633. PubMed ID: 31200360
    [No Abstract]   [Full Text] [Related]  

  • 11. Need for change in implementation of paediatric regulation.
    Vassal G; Blanc P; Pearson A
    Lancet Oncol; 2013 Nov; 14(12):1156-7. PubMed ID: 24176557
    [No Abstract]   [Full Text] [Related]  

  • 12. Fertility preservation during treatment is a growing issue for women.
    Rowan K
    J Natl Cancer Inst; 2010 Mar; 102(5):294-6. PubMed ID: 20173119
    [No Abstract]   [Full Text] [Related]  

  • 13. [Association Dermatologic Oncology (ADO). Treatment of advanced squamous cell carcinoma].
    Hillen U; Ulrich C; Gutzmer R; Becker JC
    J Dtsch Dermatol Ges; 2013 Jul; 11(7):699. PubMed ID: 23802798
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic use of erythropoietin in dermatooncology.
    Satzger I; Schenck F; Thol F; Ganser A; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2007 Apr; 5(4):280-5. PubMed ID: 17376091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Standards, Options and Recommendations: a multidisciplinary program to promote evidence-based oncology].
    Fervers B; Bey P; Maigne D; Philip T
    Bull Cancer; 2001 Jun; 88(6):601-4. PubMed ID: 11459707
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventing and managing the serious side effects of cancer chemotherapy. Consortium for the Prevention and Management of the Serious Side Effects of Cancer Chemotherapy.
    J Oncol Manag; 1997; 6(3):14-21. PubMed ID: 10174928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.
    Schnipper LE; Smith TJ; Raghavan D; Blayney DW; Ganz PA; Mulvey TM; Wollins DS
    J Clin Oncol; 2012 May; 30(14):1715-24. PubMed ID: 22493340
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug Interactions in the Treatment of Malignancy in HIV-Infected Patients.
    Welz T; Wyen C; Hensel M
    Oncol Res Treat; 2017; 40(3):120-127. PubMed ID: 28253501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Good clinical practice in chronic myeloid leukemia: advances and prospects at the Institute of Oncology of Moldova.
    Musteata V
    J BUON; 2010; 15(1):188-9. PubMed ID: 20414949
    [No Abstract]   [Full Text] [Related]  

  • 20. Oncology treatment recommendations can be supported only by 1-2% of high-quality published evidence.
    Vincent S; Djulbegovic B
    Cancer Treat Rev; 2005 Jun; 31(4):319-22. PubMed ID: 16006047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.